Efficacy and Safety Profile of Cladribine Tablets in an Italian Real-Life Cohort of Relapsing-Remitting Multiple Sclerosis Patients: A Monocentric Longitudinal Observational Study

Male MS Patients’ Safety, Tolerability and Efficacy Outcomes Do Not Differ from Female Patients Treated with Diroximel Fumarate: EVOLVE-MS-1 Ad-hoc Analysis

A Case Report: Simultaneous Presentation of Morphea and Multiple Sclerosis, a Diagnostic and Management Challenge.

Early clinical experience with cladribine tablets in a Black/Hispanic patient population